Ob/Gyn & Women’s Health Institute Outcomes
Breast Disease
Treatment
Five-Year Overall Survival of Female Patients With Breast Cancer by Raceᵃ (N = 12146)
2011-2021
| Number at Risk | Year 1 | Year 2 | Year 3 | Year 4 | Year 5 |
|---|---|---|---|---|---|
| Caucasian (N = 10553) | 8762 | 7526 | 6037 | 4696 | 3394 |
| African-American (N = 1593) | 1305 | 1111 | 875 | 675 | 477 |
ᵃSelf-Reported
Five-Year Overall Survival of Female Patients With Breast Cancer by Hormone Receptor Status (N = 9988)
2011-2021
| Number at Risk | Year 1 | Year 2 | Year 3 | Year 4 | Year 5 |
|---|---|---|---|---|---|
| ER/PR Negative (N = 1920) | 1625 | 1362 | 1132 | 893 | 669 |
| ER/PR Positive (N = 8056) | 6825 | 6039 | 5084 | 4059 | 3043 |
ER= estrogen receptor, PR= progesterone receptor
Five-Year Overall Survival of Female Patients With Breast Cancer by HER2 Status (N = 10285)
2011-2021
| Number at Risk | Year 1 | Year 2 | Year 3 | Year 4 | Year 5 |
|---|---|---|---|---|---|
| HER2 Negative (N = 8729) | 7244 | 6253 | 5130 | 3986 | 2964 |
| HER2 Positive (N = 1556) | 1358 | 1191 | 1007 | 815 | 610 |
HER2= human epidermal growth factor receptor 2
Five-Year Overall Survival of Female Patients With Stages I-III Breast Cancer by Estrogen Receptor, Progesterone Receptor, and HER2 Status (N = 9454)
2011-2021
| Number at Risk | Year 1 | Year 2 | Year 3 | Year 4 | Year 5 |
|---|---|---|---|---|---|
| ER/PR Positive (N = 6995) | 5824 | 5143 | 4327 | 3440 | 2542 |
| HER2 Positive (N = 1336) | 1177 | 1043 | 890 | 727 | 548 |
| Triple-Negative (N = 1123) | 944 | 781 | 635 | 491 | 362 |
ER= estrogen receptor, HER2= human epidermal growth factor receptor 2, PR= progesterone receptor
Five-Year Overall Survival of Female Patients With Stageᵃ 0 and I Breast Cancer (N = 7942)
2011-2021
| Number at Risk | Year 1 | Year 2 | Year 3 | Year 4 | Year 5 |
|---|---|---|---|---|---|
| Stage 0 CC (N = 1965) | 1681 | 1497 | 1240 | 1000 | 751 |
| Stage I CC (N = 5977) | 4821 | 4113 | 3214 | 2462 | 1823 |
CC= Cleveland Clinic, NCDB= National Cancer Database
ᵃAJCC stage I-IV breast cancer
ᵇReference group data from the National Cancer Database (Commission on Cancer of the American College of Surgeons and the American Cancer Society) 2000-2002, as reported in: Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A. AJCC Cancer Staging Manual. 7th ed. New York, NY: Springer Science & Business Media; 2010.
Five-Year Overall Survival of Female Patients With Stageᵃ IIA and IIB Breast Cancer (N = 3608)
2011-2021
| Number at Risk | Year 1 | Year 2 | Year 3 | Year 4 | Year 5 |
|---|---|---|---|---|---|
| Stage IIA (N = 2455) | 2186 | 1963 | 1696 | 1377 | 974 |
| Stage IIB (N = 1153) | 1007 | 868 | 728 | 574 | 411 |
CC= Cleveland Clinic, NCDB= National Cancer Database
ᵃAJCC stage I-IV breast cancer
ᵇReference group data from the National Cancer Database (Commission on Cancer of the American College of Surgeons and the American Cancer Society) 2000-2002, as reported in: Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A. AJCC Cancer Staging Manual. 7th ed. New York, NY: Springer Science & Business Media; 2010.
Five-Year Overall Survival of Female Patients With Stageᵃ IIIA and IIIB Breast Cancer (N = 937)
2011-2021
| Number at Risk | Year 1 | Year 2 | Year 3 | Year 4 | Year 5 |
|---|---|---|---|---|---|
| Stage IIIA (N = 602) | 532 | 462 | 386 | 299 | 203 |
| Stage IIIB (N = 335) | 254 | 191 | 125 | 79 | 58 |
CC= Cleveland Clinic, NCDB= National Cancer Database
ᵃAJCC stage I-IV breast cancer
ᵇReference group data from the National Cancer Database (Commission on Cancer of the American College of Surgeons and the American Cancer Society) 2000-2002, as reported in: Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A. AJCC Cancer Staging Manual. 7th ed. New York, NY: Springer Science & Business Media; 2010.
Five-Year Overall Survival of Female Patients With Late-Stage Breast Cancer (N = 1287)
2012-2022
| Number at Risk | Year 1 | Year 2 | Year 3 | Year 4 | Year 5 |
|---|---|---|---|---|---|
| Stage IIIC (N = 298) | 175 | 137 | 108 | 92 | 67 |
| Stage IV (N = 989) | 429 | 317 | 213 | 143 | 99 |
CC = Cleveland Clinic, NCDB = National Cancer Database
ᵃAJCC stage I-IV breast cancer
ᵇReference group data from the National Cancer Database (Commission on Cancer of the American College of Surgeon and the American Cancer Society) 2000-2002, as reported in: Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A. AJCC Cancer Staging Manual. 7th ed. New York, NY: Springer Science & Business Media; 2010
